Systematic Review: The Diagnosis and Staging of Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis

Alimentary Pharmacology and Therapeutics - United Kingdom
doi 10.1111/j.1365-2036.2010.04556.x
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Global Perspectives on Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis

Hepatology
MedicineHepatology
2019English

1. Fatty Liver and Non-Alcoholic Steatohepatitis

Internal Medicine
Internal MedicineMedicine
2007English

Portal Lymphadenopathy Predicts Non-Alcoholic Steatohepatitis and Advanced Fibrosis in Non-Alcoholic Fatty Liver Disease

PLoS ONE
Multidisciplinary
2018English

Diagnosis and Characterization of Non-Alcoholic Fatty Liver Disease

2018English

Diagnosis of Non-Alcoholic Fatty Liver Disease (NAFLD)

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
2016English

Therapeutic Potential of Peroxisome Proliferator-Activated Receptor Modulation in Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis

Nuclear Receptor Research
2017English

Patient-Reported Outcomes and the Economic Effects of Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis - The Value Proposition

Hepatology
MedicineHepatology
2018English

Non-Invasive Diagnosis of Fibrosis in Non-Alcoholic Fatty Liver Disease

Journal of Clinical and Experimental Hepatology
Hepatology
2012English

Non-Alcoholic Fatty Liver Disease and Disease Mongering

American Journal of Medicine
Medicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy